Patients With HIV With Burkitt’s Lymphoma Have a Worse Outcome Than Those With Diffuse Large-Cell Lymphoma Also in the Highly Active Antiretroviral Therapy Era
- 1 November 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (31) , 8132-8133
- https://doi.org/10.1200/jco.2005.02.9561
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- AIDS-Related Burkitt's Lymphoma Versus Diffuse Large-Cell Lymphoma in the Pre–Highly Active Antiretroviral Therapy (HAART) and HAART Eras: Significant Differences in Survival With Standard ChemotherapyJournal of Clinical Oncology, 2005
- Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsBlood, 2005